Adding Immune-based Treatments to Standard Glioblastoma Therapy
This clinical trial is testing standard therapy (surgery, radiation and temozolomide) plus immunotherapy with pembrolizumab with or without a cancer treatment vaccine for patients with newly diagnosed glioblastoma, a common and deadly type of brain tumor.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1097676/syndication
- Syndication ID: 17234
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, October 11, 2017 at 08:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM
Embed Code Snippet
To get the embed code snippet please Login.
